{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T19:48:31Z","timestamp":1769456911211,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T00:00:00Z","timestamp":1355270400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s12149-012-0673-5","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T04:54:56Z","timestamp":1355201696000},"page":"303-308","source":"Crossref","is-referenced-by-count":11,"title":["SPG3A-linked hereditary spastic paraplegia associated with cerebral glucose hypometabolism"],"prefix":"10.1007","volume":"27","author":[{"given":"Tatsuhiro","family":"Terada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuomi","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Hamaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kanaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Miyajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,12]]},"reference":[{"key":"673_CR1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00019052-199708000-00006","volume":"10","author":"JK Fink","year":"1997","unstructured":"Fink JK. Advances in hereditary spastic paraplegia. Curr Opin Neurol. 1997;10:313\u20138.","journal-title":"Curr Opin Neurol"},{"key":"673_CR2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S1474-4422(08)70258-8","volume":"7","author":"S Salinas","year":"2008","unstructured":"Salinas S, Proukakis C, Crosby A, Warner TT. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol. 2008;7:1127\u201338.","journal-title":"Lancet Neurol"},{"key":"673_CR3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ng758","volume":"29","author":"X Zhao","year":"2001","unstructured":"Zhao X, Alvarado D, Rainier S, Lemons R, Hedera P, Weber CH, et al. Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat Genet. 2001;29:326\u201331.","journal-title":"Nat Genet"},{"key":"673_CR4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/WCO.0b013e3282f190ba","volume":"20","author":"C Depienne","year":"2007","unstructured":"Depienne C, Stevanin G, Brice A, Durr A. Hereditary spastic paraplegias: an update. Curr Opin Neurol. 2007;20:674\u201380.","journal-title":"Curr Opin Neurol"},{"key":"673_CR5","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/archneur.61.10.1600","volume":"61","author":"P Hedera","year":"2004","unstructured":"Hedera P, Fenichel GM, Blair M, Haines JL. Novel mutation in the SPG3A gene in an African American family with an early onset of hereditary spastic paraplegia. Arch Neurol. 2004;61:1600\u20133.","journal-title":"Arch Neurol"},{"key":"673_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10048-004-0191-2","volume":"5","author":"A Abel","year":"2004","unstructured":"Abel A, Fonknechten N, Hofer A, Durr A, Cruaud C, Voit T, et al. Early onset autosomal dominant spastic paraplegia caused by novel mutations in SPG3A. Neurogenetics. 2004;5:239\u201343.","journal-title":"Neurogenetics"},{"key":"673_CR7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-510X(03)00210-7","volume":"216","author":"PA Wilkinson","year":"2003","unstructured":"Wilkinson PA, Hart PE, Patel H, Warner TT, Crosby AH. SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia. J Neurol Sci. 2003;216:43\u20135.","journal-title":"J Neurol Sci"},{"key":"673_CR8","doi-asserted-by":"crossref","first-page":"49063","DOI":"10.1074\/jbc.M306702200","volume":"278","author":"PP Zhu","year":"2003","unstructured":"Zhu PP, Patterson A, Lavoie B, Stadler J, Shoeb M, Patel R, et al. Cellular localization, oligomerization, and membrane association of the hereditary spastic paraplegia 3A (SPG3A) protein atlastin. J Biol Chem. 2003;278:49063\u201371.","journal-title":"J Biol Chem"},{"key":"673_CR9","first-page":"1238","volume":"36","author":"S Minoshima","year":"1995","unstructured":"Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36:1238\u201348.","journal-title":"J Nucl Med"},{"key":"673_CR10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00415-005-0768-1","volume":"252","author":"V Scarano","year":"2005","unstructured":"Scarano V, Mancini P, Criscuolo C, De Michele G, Rinaldi C, Tucci T, et al. The R495W mutation in SPG3A causes spastic paraplegia associated with axonal neuropathy. J Neurol. 2005;252:901\u20133.","journal-title":"J Neurol"},{"key":"673_CR11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/archneur.64.5.706","volume":"64","author":"N Ivanova","year":"2007","unstructured":"Ivanova N, Claeys KG, Deconinck T, Litvinenko I, Jordanova A, Auer-Grumbach M, et al. Hereditary spastic paraplegia 3A associated with axonal neuropathy. Arch Neurol. 2007;64:706\u201313.","journal-title":"Arch Neurol"},{"key":"673_CR12","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.braindev.2009.08.003","volume":"32","author":"C Fusco","year":"2010","unstructured":"Fusco C, Frattini D, Farnetti E, Nicoli D, Casali B, Fiorentino F, et al. Hereditary spastic paraplegia and axonal motor neuropathy caused by a novel SPG3A de novo mutation. Brain Dev. 2010;32:592\u20134.","journal-title":"Brain Dev"},{"key":"673_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2007.01.012","volume":"35","author":"M Namekawa","year":"2007","unstructured":"Namekawa M, Muriel MP, Janer A, Latouche M, Dauphin A, Debeir T, et al. Mutations in the SPG3A gene encoding the GTPase atlastin interfere with vesicle trafficking in the ER\/Golgi interface and Golgi morphogenesis. Mol Cell Neurosci. 2007;35:1\u201313.","journal-title":"Mol Cell Neurosci"},{"key":"673_CR14","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/hmg\/ddn046","volume":"17","author":"N Rismanchi","year":"2008","unstructured":"Rismanchi N, Soderblom C, Stadler J, Zhu PP, Blackstone C. Atlastin GTPases are required for Golgi apparatus and er morphogenesis. Hum Mol Genet. 2008;17:1591\u2013604.","journal-title":"Hum Mol Genet"},{"key":"673_CR15","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.1471-4159.2009.06258.x","volume":"110","author":"MP Muriel","year":"2009","unstructured":"Muriel MP, Dauphin A, Namekawa M, Gervais A, Brice A, Ruberg M. Atlastin-1, the dynamin-like GTPase responsible for spastic paraplegia SPG3A, remodels lipid membranes and may form tubules and vesicles in the endoplasmic reticulum. J Neurochem. 2009;110:1607\u201316.","journal-title":"J Neurochem"},{"key":"673_CR16","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/nature08280","volume":"460","author":"G Orso","year":"2009","unstructured":"Orso G, Pendin D, Liu S, Tosetto J, Moss TJ, Faust JE, et al. Homotypic fusion of er membranes requires the dynamin-like GTPase atlastin. Nature. 2009;460:978\u201383.","journal-title":"Nature"},{"key":"673_CR17","doi-asserted-by":"crossref","first-page":"10666","DOI":"10.1073\/pnas.0510863103","volume":"103","author":"K Evans","year":"2006","unstructured":"Evans K, Keller C, Pavur K, Glasgow K, Conn B, Lauring B. Interaction of two hereditary spastic paraplegia gene products, spastin and atlastin, suggests a common pathway for axonal maintenance. Proc Natl Acad Sci USA. 2006;103:10666\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"673_CR18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/hmg\/ddi447","volume":"15","author":"CM Sanderson","year":"2006","unstructured":"Sanderson CM, Connell JW, Edwards TL, Bright NA, Duley S, Thompson A, et al. Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners. Hum Mol Genet. 2006;15:307\u201318.","journal-title":"Hum Mol Genet"},{"key":"673_CR19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/01.WNL.0000108629.04434.05","volume":"62","author":"P McMonagle","year":"2004","unstructured":"McMonagle P, Byrne P, Hutchinson M. Further evidence of dementia in SPG4-linked autosomal dominant hereditary spastic paraplegia. Neurology. 2004;62:407\u201310.","journal-title":"Neurology"},{"key":"673_CR20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.0b013e3181b04c6c","volume":"73","author":"S Murphy","year":"2009","unstructured":"Murphy S, Gorman G, Beetz C, Byrne P, Dytko M, McMonagle P, et al. Dementia in SPG4 hereditary spastic paraplegia: clinical, genetic, and neuropathologic evidence. Neurology. 2009;73:378\u201384.","journal-title":"Neurology"},{"key":"673_CR21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jns.2005.03.051","volume":"235","author":"KH Scheuer","year":"2005","unstructured":"Scheuer KH, Nielsen JE, Krabbe K, Simonsen C, Koefoed P, Sorensen SA, et al. Reduced regional cerebral blood flow in SPG4-linked hereditary spastic paraplegia. J Neurol Sci. 2005;235:23\u201332.","journal-title":"J Neurol Sci"},{"key":"673_CR22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/hmg\/ddg004","volume":"12","author":"D Charvin","year":"2003","unstructured":"Charvin D, Cifuentes-Diaz C, Fonknechten N, Joshi V, Hazan J, Melki J, et al. Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus. Hum Mol Genet. 2003;12:71\u20138.","journal-title":"Hum Mol Genet"},{"key":"673_CR23","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/jnen\/62.11.1166","volume":"62","author":"SB Wharton","year":"2003","unstructured":"Wharton SB, McDermott CJ, Grierson AJ, Wood JD, Gelsthorpe C, Ince PG, et al. The cellular and molecular pathology of the motor system in hereditary spastic paraparesis due to mutation of the spastin gene. J Neuropathol Exp Neurol. 2003;62:1166\u201377.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 6","key":"673_CR24","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/brain\/119.6.2105","volume":"119","author":"S Abrahams","year":"1996","unstructured":"Abrahams S, Goldstein LH, Kew JJ, Brooks DJ, Lloyd CM, Frith CD, et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis. A pet study. Brain. 1996;119(Pt 6):2105\u201320.","journal-title":"Brain"},{"key":"673_CR25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nmd.2008.10.002","volume":"19","author":"MM Graaff van der","year":"2009","unstructured":"van der Graaff MM, de Jong JM, Baas F, de Visser M. Upper motor neuron and extra-motor neuron involvement in amyotrophic lateral sclerosis: a clinical and brain imaging review. Neuromuscul Disord. 2009;19:53\u20138.","journal-title":"Neuromuscul Disord"},{"key":"673_CR26","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/01.WNL.0000055861.95202.8D","volume":"60","author":"C Lomen-Hoerth","year":"2003","unstructured":"Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003;60:1094\u20137.","journal-title":"Neurology"},{"key":"673_CR27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/archneurol.2008.558","volume":"66","author":"F Geser","year":"2009","unstructured":"Geser F, Martinez-Lage M, Robinson J, Uryu K, Neumann M, Brandmeir NJ, et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol. 2009;66:180\u20139.","journal-title":"Arch Neurol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-012-0673-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-012-0673-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-012-0673-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T04:41:23Z","timestamp":1559450483000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-012-0673-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,12]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["673"],"URL":"https:\/\/doi.org\/10.1007\/s12149-012-0673-5","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,12]]}}}